Winstrol (Stanozolol) — Dosing, Cycles, Half-Life & Side Effects

Winstrol (Stanozolol) is an oral anabolic-androgenic steroid with a half-life of 8-9 hours. DHT derivative for cutting and hardness. Primary risks include significant hepatotoxicity, liver stress typical of 17α-alkylated orals. This page is educational harm-reduction reference compiled from peer-reviewed literature — not medical advice, not an endorsement, not a recommendation to use. Consult a licensed clinician before any decision.

Quick Facts

ClassOrals
Half-life8-9 hours
Detection window60 days
AromatizationNo
HepatotoxicityHigh
Suppression6/10
17α-alkylatedYes
Administrationoral

Typical Dosing Ranges

Common dose range: 20-50mg/day

Cycle length: 6 weeks max

Time to steady state: ~2 days

Dose ranges are compiled from published pharmacokinetic studies and community-reported usage. Where a value is community-reported rather than clinically studied, this page and its structured data flag it. Lower end of any range is always the safer starting point.

Stacking Considerations

  • Do not stack with another 17α-alkylated oral. Dual-17αα stacking is prohibited in StackItSmart and unsafe for the liver.

PCT Requirements

  • This compound causes clinically meaningful HPTA suppression. Post-cycle therapy is recommended.
  • Depot clearance estimate: ~2 days post-last-dose before SERM start (5 × apparent depot half-life of 9h).
  • Never stack two SERMs. Extend a single SERM (tamoxifen OR enclomiphene/clomiphene) rather than combining.
  • Use the cycle planner to generate a full protocol based on your complete stack, not this compound alone.

Side Effect Profile

  • Liver toxic
  • Hair loss
  • Joint pain
  • Suppression

Known Interactions

  • Both are 17-alpha alkylated orals causing significant liver strain.

    Recommendation: Avoid combining. If absolutely necessary, limit to 4 weeks max with liver support.

    Monitor: AST, ALT, GGT

  • Both can affect lipids and stress liver/kidneys.

    Recommendation: If combining, keep cycle short and support organs.

    Monitor: Creatinine, BUN, Lipid panel

Monitoring (Bloodwork & Vitals)

  • Comprehensive metabolic panel (baseline, mid-cycle, post-cycle)
  • Lipid panel (total cholesterol, HDL, LDL, triglycerides)
  • CBC (hemoglobin, hematocrit — watch for erythrocytosis)
  • Sex-hormone panel (Total T, Free T, Estradiol sensitive, SHBG, LH, FSH)
  • Liver enzymes (ALT, AST, GGT) every 2–4 weeks on oral 17αα cycles
  • Blood pressure (weekly self-check; flag systolic >140 or diastolic >90)

Baseline bloodwork is recommended before any cycle. Discontinue if liver enzymes exceed 3× upper limit of normal or if hematocrit exceeds 54%.

Frequently Asked Questions

What is the half-life of Winstrol (Stanozolol)?

Winstrol (Stanozolol) has a half-life of approximately 8-9 hours. Clearance estimate: 9h � 5 = 45h = 2 days. This figure is used to determine injection frequency (for esters) and post-cycle clearance timing.

What is the typical dose range for Winstrol (Stanozolol)?

Commonly reported ranges for Winstrol (Stanozolol): 20-50mg/day. Cycle length: 6 weeks max. These are compiled from published studies and community-reported usage — individual response varies and lower end is always preferred.

Does Winstrol (Stanozolol) suppress natural testosterone?

Winstrol (Stanozolol) causes strong suppression of the HPTA axis (score 6/10). Post-cycle therapy (PCT) is recommended after use.

Is Winstrol (Stanozolol) liver toxic?

Hepatotoxicity rating: High. Winstrol (Stanozolol) is 17α-alkylated, which bypasses first-pass liver metabolism and increases hepatic stress. Oral 17αα cycles should be capped at 6 weeks and paired with liver monitoring (ALT/AST every 2–4 weeks).

Does Winstrol (Stanozolol) aromatize to estrogen?

Aromatization profile: No. Minimal to no aromatization expected, so aromatase inhibitors are not typically indicated for this compound alone.

What is Winstrol (Stanozolol) typically used for?

Winstrol (Stanozolol) is commonly used for: Cutting, Contest prep, Intermediate users. Intended-use context does not imply safety — every use case carries the same underlying pharmacological risks.

Citations

  1. Hartgens F, Kuipers H. 2004. Sports Med — Half-life approximately 9 hours oral, 24 hours injectable for stanozolol
  2. Liu et al.. 2025. Substance Use & Misuse — AAS meta-analysis: SBP +12.43 mmHg (95% CI: 9.59-15.26), LDL-C +9.12 mg/dL (95% CI: 6.75-11.49)
  3. Hartgens F, et al. Effects of androgenic-anabolic steroids in athletes. Sports Med 2004

Disclaimer

StackItSmart is an independent harm-reduction reference. The content above is compiled from peer-reviewed literature and is not medical advice, not an endorsement, and not a recommendation to use Winstrol (Stanozolol). Performance-enhancing compounds carry legal, endocrine, cardiovascular, and hepatic risks. Consult a licensed clinician before any decision. StackItSmart does not provide sourcing, procurement, or dosing prescriptions.

Skip to main content